News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
149,752 Results
Type
Article (6061)
Company Profile (55)
Press Release (143636)
Section
Business (53060)
Career Advice (172)
Deals (9294)
Drug Delivery (7)
Drug Development (20706)
Employer Resources (22)
FDA (3449)
Job Trends (3509)
News (83888)
Policy (6408)
Tag
Academia (513)
Alliances (6819)
Alzheimer's disease (345)
Approvals (3445)
Artificial intelligence (18)
Bankruptcy (50)
Best Places to Work (3138)
Biotechnology (44)
Breast cancer (34)
Cancer (286)
Cardiovascular disease (19)
Career advice (146)
Cell therapy (39)
Clinical research (16585)
Collaboration (52)
Compensation (23)
COVID-19 (985)
Cystic fibrosis (22)
Data (373)
Diabetes (26)
Diagnostics (1540)
Earnings (37093)
Employer resources (21)
Events (24284)
Executive appointments (22)
FDA (3552)
Funding (31)
Gene therapy (23)
GLP-1 (110)
Government (1060)
Healthcare (5237)
Infectious disease (1002)
Inflammatory bowel disease (40)
Interviews (23)
IPO (6021)
Job creations (528)
Job search strategy (131)
Layoffs (53)
Legal (990)
Lung cancer (49)
Manufacturing (20)
Medical device (3607)
Medtech (3607)
Mergers & acquisitions (3298)
Metabolic disorders (68)
Neuroscience (396)
NextGen Class of 2024 (1131)
Non-profit (1007)
Northern California (368)
Obesity (36)
People (7682)
Phase I (4330)
Phase II (7167)
Phase III (6680)
Pipeline (202)
Postmarket research (681)
Preclinical (1557)
Radiopharmaceuticals (56)
Rare diseases (42)
Real estate (736)
Regulatory (4641)
Research institute (511)
Resumes & cover letters (25)
Southern California (307)
Startups (505)
United States (3008)
Vaccines (232)
Weight loss (19)
Date
Today (109)
Last 7 days (403)
Last 30 days (976)
Last 365 days (9099)
2024 (8137)
2023 (10572)
2022 (11860)
2021 (32762)
2020 (12065)
2019 (9430)
2018 (6995)
2017 (6722)
2016 (5373)
2015 (7178)
2014 (4888)
2013 (3426)
2012 (3755)
2011 (4212)
2010 (3658)
Location
Africa (97)
Asia (9065)
Australia (1233)
California (755)
Canada (307)
China (43)
Colorado (26)
Connecticut (41)
Delaware (30)
Europe (20322)
Florida (95)
Georgia (27)
Illinois (60)
Indiana (47)
Japan (19)
Kansas (50)
Maryland (95)
Massachusetts (558)
Michigan (29)
Minnesota (70)
New Hampshire (18)
New Jersey (267)
New York (220)
North Carolina (155)
Northern California (368)
Ohio (20)
Pennsylvania (197)
South America (191)
Southern California (307)
Texas (85)
Utah (28)
Washington State (108)
149,752 Results for "23".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
23andMe Holding Co. and Nightingale Health Plc announced a strategic collaboration to pilot Nightingale Health’s clinically-validated and cost-effective blood metabolomics panel with a cohort of 23andMe members.
June 28, 2024
·
4 min read
Biotech Bay
23andMe Launches New Genetic Report on Bipolar Disorder
23andMe Holding Co., a leading human genetics and biopharmaceutical company, released a new genetic Bipolar Disorder report for 23andMe+ Premium members, informing them if they are at higher likelihood for being diagnosed with the condition.
June 5, 2024
·
4 min read
Press Releases
23andMe to Report Q2 FY2025 Financial Results
November 8, 2024
·
3 min read
Press Releases
23andMe Appoints Three New Independent Directors to Board
October 29, 2024
·
4 min read
Annual General Meeting in Cantargia AB (publ) - May 23, 2024
Cantargia’s Annual General Meeting on 23 May 2024 resolved in accordance with the following.
May 23, 2024
·
3 min read
Press Releases
CORRECTION - 23andMe to Report Q2 FY2025 Financial Results
November 8, 2024
·
3 min read
Press Releases
23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024
September 3, 2024
·
7 min read
Biotech Bay
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
23andMe Holding Co. presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31-June 4.
June 3, 2024
·
7 min read
Business
Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024
Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2024 financial results on Tuesday, July 23, 2024, before the market opens.
June 19, 2024
·
1 min read
Press Releases
Pharvaris to Host Virtual Investor Event on October 23, 2024
October 15, 2024
·
1 min read
1 of 14,976
Next
